 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, June 9, 2004, 24(23):5331-5335; doi:10.1523/JNEUROSCI.1124-04.2004
Previous Article | Next Article
BRIEF COMMUNICATION
Catechol-O-Methyltransferase Inhibition Improves Set-Shifting Performance and Elevates Stimulated Dopamine Release in the Rat Prefrontal Cortex
E. M. Tunbridge,1 D. M. Bannerman,2 T. Sharp,3 andP. J. Harrison1 1Department of Psychiatry, University of Oxford, Oxford, United Kingdom, OX3 7JX, 2Department of Experimental Psychology, University of Oxford, Oxford, OX1 3UD, United Kingdom, and 3Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, United Kingdom
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene affects activity of the enzyme and influences performance and efficiency of the prefrontal cortex (PFC); however, although catecholaminergic neurotransmission is implicated, the underlying mechanisms remain elusive because studies of the role of COMT in PFC function are sparse. This study investigated the effect of tolcapone, a brain-penetrant COMT inhibitor, on a rat model of attentional set shifting, which is dependent on catecholamines and the medial PFC (mPFC). Additionally, we investigated the effect of tolcapone on extracellular catecholamines in the mPFC using microdialysis in awake rats. Tolcapone significantly and specifically improved extradimensional (ED) set shifting. Tolcapone did not affect basal extracellular catecholamines, but significantly potentiated the increase in extracellular dopamine (DA) elicited by either local administration of the depolarizing agent potassium chloride or systemic administration of the antipsychotic agent clozapine. Although extracellular norepinephrine (NE) was also elevated by local depolarization and clozapine, the increase was not enhanced by tolcapone.
We conclude that COMT activity specifically affects ED set shifting and is a significant modulator of mPFC DA but not NE under conditions of increased catecholaminergic transmission. These data suggest that the links between COMT activity and PFC function can be modeled in rats and may be specifically mediated by DA. The interaction between clozapine and tolcapone may have implications for the treatment of schizophrenia.
Key words: tolcapone; clozapine; catecholamine; norepinephrine; working memory; antipsychotic
Received Jan 26, 2004; revised April 27, 2004; accepted April 27, 2004.
This article has been cited by other articles:
F. Papaleo, J. N. Crawley, J. Song, B. K. Lipska, J. Pickel, D. R. Weinberger, and J. Chen
Genetic Dissection of the Role of Catechol-O-Methyltransferase in Cognition and Stress Reactivity in Mice
J. Neurosci., August 27, 2008; 28(35): 8709 - 8723.
[Abstract] [Full Text] [PDF]
A. B. Hains and A. F.T. Arnsten
Molecular mechanisms of stress-induced prefrontal cortical impairment: Implications for mental illness
Learn. Mem., August 6, 2008; 15(8): 551 - 564.
[Abstract] [Full Text] [PDF]
M. J. Frank, A. A. Moustafa, H. M. Haughey, T. Curran, and K. E. Hutchison
Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning
PNAS, October 9, 2007; 104(41): 16311 - 16316.
[Abstract] [Full Text] [PDF]
L. Yavich, M. M. Forsberg, M. Karayiorgou, J. A. Gogos, and P. T. Mannisto
Site-Specific Role of Catechol-O-Methyltransferase in Dopamine Overflow within Prefrontal Cortex and Dorsal Striatum
J. Neurosci., September 19, 2007; 27(38): 10196 - 10209.
[Abstract] [Full Text] [PDF]
T. Robbins and A. Roberts
Differential Regulation of Fronto-Executive Function by the Monoamines and Acetylcholine
Cereb Cortex, September 1, 2007; 17(suppl_1): i151 - i160.
[Abstract] [Full Text] [PDF]
H. J. Williams, M. J. Owen, and M. C. O'Donovan
Is COMT a Susceptibility Gene for Schizophrenia?
Schizophr Bull, May 1, 2007; 33(3): 635 - 641.
[Abstract] [Full Text] [PDF]
E. Tunbridge, C. Weickert, J. Kleinman, M. Herman, J Chen, B. Kolachana, P. Harrison, and D. Weinberger
Catechol-o-Methyltransferase Enzyme Activity and Protein Expression in Human Prefrontal Cortex across the Postnatal Lifespan
Cereb Cortex, May 1, 2007; 17(5): 1206 - 1212.
[Abstract] [Full Text] [PDF]
E. M. Drabant, A. R. Hariri, A. Meyer-Lindenberg, K. E. Munoz, V. S. Mattay, B. S. Kolachana, M. F. Egan, and D. R. Weinberger
Catechol O-methyltransferase Val158Met Genotype and Neural Mechanisms Related to Affective Arousal and Regulation
Arch Gen Psychiatry, December 1, 2006; 63(12): 1396 - 1406.
[Abstract] [Full Text] [PDF]
H. M. Abdolmaleky, K.-h. Cheng, S. V. Faraone, M. Wilcox, S. J. Glatt, F. Gao, C. L. Smith, R. Shafa, B. Aeali, J. Carnevale, et al.
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Hum. Mol. Genet., November 1, 2006; 15(21): 3132 - 3145.
[Abstract] [Full Text] [PDF]
Y. D. Black, F. R. Maclaren, A. V. Naydenov, W. A. Carlezon Jr, M. G. Baxter, and C. Konradi
Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence.
J. Neurosci., September 20, 2006; 26(38): 9656 - 9665.
[Abstract] [Full Text] [PDF]
B. K. Lipska, S. Mitkus, M. Caruso, T. M. Hyde, J. Chen, R. Vakkalanka, R. E. Straub, D. R. Weinberger, and J. E. Kleinman
RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity
Hum. Mol. Genet., September 15, 2006; 15(18): 2804 - 2812.
[Abstract] [Full Text] [PDF]
M. R. Stefani and B. Moghaddam
Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum.
J. Neurosci., August 23, 2006; 26(34): 8810 - 8818.
[Abstract] [Full Text] [PDF]
A. Bertolino, G. Blasi, V. Latorre, V. Rubino, A. Rampino, L. Sinibaldi, G. Caforio, V. Petruzzella, A. Pizzuti, T. Scarabino, et al.
Additive Effects of Genetic Variation in Dopamine Regulating Genes on Working Memory Cortical Activity in Human Brain
J. Neurosci., April 12, 2006; 26(15): 3918 - 3922.
[Abstract] [Full Text] [PDF]
B. H. Schott, C. I. Seidenbecher, D. B. Fenker, C. J. Lauer, N. Bunzeck, H.-G. Bernstein, W. Tischmeyer, E. D. Gundelfinger, H.-J. Heinze, and E. Duzel
The Dopaminergic Midbrain Participates in Human Episodic Memory Formation: Evidence from Genetic Imaging
J. Neurosci., February 1, 2006; 26(5): 1407 - 1417.
[Abstract] [Full Text] [PDF]
T. Ohnishi, R. Hashimoto, T. Mori, K. Nemoto, Y. Moriguchi, H. Iida, H. Noguchi, T. Nakabayashi, H. Hori, M. Ohmori, et al.
The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia
Brain, February 1, 2006; 129(2): 399 - 410.
[Abstract] [Full Text] [PDF]
J. J Hagan and D. N C Jones
Predicting Drug Efficacy for Cognitive Deficits in Schizophrenia
Schizophr Bull, October 1, 2005; 31(4): 830 - 853.
[Abstract] [Full Text] [PDF]
S. B. Glickstein, D. A. DeSteno, P. R. Hof, and C. Schmauss
Mice Lacking Dopamine D2 and D3 Receptors Exhibit Differential Activation of Prefrontal Cortical Neurons during Tasks Requiring Attention
Cereb Cortex, July 1, 2005; 15(7): 1016 - 1024.
[Abstract] [Full Text] [PDF]
G. Blasi, V. S. Mattay, A. Bertolino, B. Elvevag, J. H. Callicott, S. Das, B. S. Kolachana, M. F. Egan, T. E. Goldberg, and D. R. Weinberger
Effect of Catechol-O-Methyltransferase val158met Genotype on Attentional Control
J. Neurosci., May 18, 2005; 25(20): 5038 - 5045.
[Abstract] [Full Text] [PDF]
M. N. Smolka, G. Schumann, J. Wrase, S. M. Grusser, H. Flor, K. Mann, D. F. Braus, D. Goldman, C. Buchel, and A. Heinz
Catechol-O-Methyltransferase val158met Genotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal Cortex
J. Neurosci., January 26, 2005; 25(4): 836 - 842.
[Abstract] [Full Text] [PDF]
H. F. Clarke, S. C. Walker, H. S. Crofts, J. W. Dalley, T. W. Robbins, and A. C. Roberts
Prefrontal Serotonin Depletion Affects Reversal Learning But Not Attentional Set Shifting
J. Neurosci., January 12, 2005; 25(2): 532 - 538.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|